Increasing Prevalence of Allergies Has Propelled the Growth of the Loratadine Syrup Market in the North America Region!

In North America, loratadine syrup holds several advantages and benefits for both adults and children in managing allergic conditions. The region experiences a high prevalence of allergies, including allergic rhinitis and urticaria, making loratadine syrup a valuable treatment option. Its availability as an over-the-counter medication allows individuals to easily access and use it for relief from allergy symptoms without the need for a prescription. This convenience promotes self-care and empowers individuals to take control of their allergies. The liquid formulation of loratadine syrup offers ease of administration, particularly beneficial for children and those with difficulty swallowing tablets. Additionally, the non-drowsy formula of loratadine syrup ensures individuals can go about their daily activities without experiencing excessive sedation. Also, the availability, convenience, non-drowsy nature, and efficacy of loratadine syrup make it a popular choice for managing allergies in North America, catering to the diverse needs of adults and children seeking effective symptom relief.

Access sample report (including graphs, charts, and figures):https://univdatos.com/report/loratadine-syrup-market/get-a-free-sample-form.php?product_id=41462

Further,the North America loratadine syrup market is expected to grow at a strong CAGR of 2% during the forecast period (2022-2030). This is mainly due to the growing awareness about allergies and their impact on health, coupled with the urbanization and environmental factors contributing to allergen exposure, which has bolstered the market demand for loratadine syrup.

North America Loratadine Syrup Market Revenue (2020-2030)- USD Mn

For a detailed analysis of the Global Loratadine Syrup Market browse through– https://univdatos.com/report/loratadine-syrup-market/

On the basis of indication, the market is categorized into allergic rhinitis and urticaria. Among these, allergic rhinitis held a significant share of the market in 2021. This is mainly due to the growing investment & funding activities by government bodies and the rising prevalence of allergic rhinitis all over the world. For instance, as per the National Institutes of Health (NIH), around 339 million are suffering from asthma, 200 to 250 million have food allergies and 400 million have rhinitis globally.

Based on drug type, the loratadine syrup market has been classified into branded and generic. The branded category is to witness higher adoption of loratadine syrup during the forecast period. This is mainly due to the pharmaceutical companies spending on marketing & branding and their loyalty being higher. Also, brand-name pills are usually the first version of the drug on the market, and this specific version has undergone careful testing to ensure efficacy to consumers.

Global Loratadine Syrup Market Segmentation

Market Insight, by Age

• Adult
• Pediatric

Market Insights, by Indication

• Allergic Rhinitis
• Urticaria

Market Insights, by Drug Type

• Branded
• Generic

Market Insight, by Region

• North America
  • U.S.
  • Canada
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• APAC
  • China
  • India
  • Japan
  • Rest of APAC
• Rest of the World

Top Company Profiles

• Merck KGaA
• Cadila Pharmaceuticals• Medico Remedies Limited• Sun Pharmaceutical Industries Ltd.• GSK plc.• Perrigo Company plc,• Novartis AG• Taro Pharmaceutical Industries Ltd.• Dr. Reddy’s Laboratories Ltd.• Bayer Inc.